Plasma Nitrotyrosine as an Indicator of Nitric Oxide Derived Oxidant Stress in Infants With Bronchopulmonary Dysplasia. † 1935

Pediatric Research - United States
doi 10.1203/00006450-199604001-01959
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Can Nitric Oxide–Based Therapy Prevent Bronchopulmonary Dysplasia?

Clinics in Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2012English

Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia

Korean Journal of Pediatrics
2010English

Longitudinal Measures of Lung Function in Infants With Bronchopulmonary Dysplasia

Pediatric Pulmonology
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2010English

Nitric Oxide as an Indicator for Severity of Injury in Polytrauma

Bratislava Medical Journal
2016English

Nitrotyrosine (NT) in Fatal Respiratory Failure in Infants: Influence of Inhaled Nitric Oxide (iNO) Treatment

Pediatric Research
Child HealthPediatricsPerinatology
1998English

Predictors of Bronchopulmonary Dysplasia in Saudi Preterm Infants

Annals of Neonatology Journal
2020English

Ventilatory Control in Infants, Children, and Adults With Bronchopulmonary Dysplasia

Respiratory Physiology and Neurobiology
NeurosciencePulmonaryRespiratory MedicinePhysiology
2013English

29 Ventilation and Perfusion Abnormalities in Infants With Bronchopulmonary Dysplasia

Pediatric Research
Child HealthPediatricsPerinatology
2010English

PS-207 Plasma Pro-Endothelin-1 as Marker of Bronchopulmonary Dysplasia

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy